Home > Insider Trading > Filing (0001140361-17-025714)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1561387	Health Insurance Innovations Inc.	HIIQ	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1366008	Sheldon Wang	C/O Health Insurance Innovations, Inc. 15438 N. Florida Ave., Suite 201 Tampa FL 33613	Chief Technology Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Common Stock	Acquisiton	2017-06-14	23,826	$6.77	262,577	No	4	M	Direct
Class A Common Stock	Disposition	2017-06-14	2,319	$21.90	260,258	No	4	D	Direct
Class A Common Stock	Disposition	2017-06-14	751	$22.20	259,507	No	4	D	Direct
Class A Common Stock	Disposition	2017-06-14	2,330	$21.80	257,177	No	4	D	Direct
Class A Common Stock	Disposition	2017-06-14	2,005	$21.50	255,172	No	4	D	Direct
Class A Common Stock	Disposition	2017-06-14	16,421	$21.79	238,751	No	4	S	Direct
Class A Common Stock	Disposition	2017-06-19	10,000	$24.95	228,751	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	D	Direct
No	4	D	Direct
No	4	D	Direct
No	4	D	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Common Stock	Stock Appreciation Rights	Disposition	2017-06-14	23,826	$0.00	23,826	$6.77

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
41,039		2021-05-25	No	4	M	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Class A Common Stock	Stock Appreciation Rights	$12.13		2021-07-14	6,000	6,000	Direct
Class A Common Stock	Stock Appreciation Rights	$4.95		2022-07-01	30,000	30,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-07-14	6,000	6,000	Direct
2022-07-01	30,000	30,000	Direct

Footnotes

Shares retained by the issuer to satisfy the exercise price of stock appreciation rights exercised by the reporting person.
The price in Column 4 is a weighted average price. The prices actually received ranged from $21.50 to $22.20. The reporting person has provided to the issuer, and will provide to any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range for all transactions reported in this Form 4 utilizing a weighted average price.
These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in November, 2016.
These stock-settled stock appreciation rights were granted under the Issuer's Long Term Incentive Plan (the "Plan") and are vested as of the date of this Form 4.
These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 20%, 20%, 20%, and 40% on successive anniversary dates of the grant, subject to the terms of the plan and an award agreement under the plan.
These stock-settled stock appreciation rights were previously granted under the Plan and are scheduled to vest in increments of 25%, 25%, and 50% on successive anniversary dates of the grant, subject to the terms of the Plan and an award agreement under the Plan.